Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-22-031236)

Filing Details

Accession Number:: 0001209191-22-031236
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-05-23 06:09:42
Reporting Period:: 2022-05-19

Accepted Time:: 2022-05-23 06:09:42
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1574094	Renovorx Inc.	RNXT	Pharmaceutical Preparations (2834)	271448452

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1862613	Shaun Bagai	C/O Renovorx, Inc. 4546 El Camino Real, Suite B1 Los Altos CA 94022	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-05-19	5,500	$2.05	251,557	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

Includes 246,057 shares previously reported on a Form 3 filed on August 25, 2021 as a fully vested stock option exercisable at $0.15 per share. The option was exercised in full prior to the Issuer's initial public offering.